MARC details
| 000 -CABECERA |
|---|
| campo de control de longitud fija |
06061cam a2200433M 4500 |
| 001 - NÚMERO DE CONTROL |
|---|
| campo de control |
96118 |
| 003 - IDENTIFICADOR DEL NÚMERO DE CONTROL |
|---|
| campo de control |
ES-MaUEC |
| 005 - FECHA Y HORA DE LA ÚLTIMA TRANSACCIÓN |
|---|
| campo de control |
20230102112739.0 |
| 006 - CÓDIGOS DE INFORMACIÓN DE LONGITUD FIJA--CARACTERÍSTICAS DEL MATERIAL ADICIONAL |
|---|
| campo de control de longitud fija |
m o d |
| 007 - CAMPO FIJO DE DESCRIPCIÓN FÍSICA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
cr |n||||||||| |
| 008 - DATOS DE LONGITUD FIJA--INFORMACIÓN GENERAL |
|---|
| campo de control de longitud fija |
170602s2017 sz o 000 0 eng d |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| Número Internacional Estándar del Libro |
3319573713 |
| Información calificativa |
(electronic bk.) |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| Número Internacional Estándar del Libro |
9783319573717 |
| Información calificativa |
(electronic bk.) |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| ISBN cancelado o inválido |
3319573691 |
| 020 ## - NÚMERO INTERNACIONAL ESTÁNDAR DEL LIBRO |
|---|
| ISBN cancelado o inválido |
9783319573694 |
| 040 ## - FUENTE DE LA CATALOGACIÓN |
|---|
| Centro catalogador/agencia de origen |
YDX |
| Centro/agencia transcriptor |
YDX |
| Centro/agencia modificador |
N$T |
| -- |
EBLCP |
| -- |
N$T |
| -- |
GW5XE |
| -- |
UAB |
| -- |
ESU |
| -- |
AZU |
| -- |
UPM |
| -- |
IOG |
| -- |
COO |
| -- |
MERER |
| -- |
OCLCQ |
| -- |
U3W |
| -- |
ES-MaUEC |
| Lengua de catalogación |
spa |
| 050 #4 - SIGNATURA TOPOGRÁFICA DE LA BIBLIOTECA DEL CONGRESO |
|---|
| Número de clasificación |
QP801.C27 |
| Número de documento/Ítem |
E536 2017 EB |
| 245 00 - MENCIÓN DE TÍTULO |
|---|
| Título |
Endocannabinoids and lipid mediators in brain functions |
| Mención de responsabilidad, etc. |
Miriam Melis, editor. |
| 264 #1 - PRODUCCIÓN, PUBLICACIÓN, DISTRIBUCIÓN, FABRICACIÓN Y COPYRIGHT |
|---|
| Producción, publicación, distribución, fabricación y copyright |
Cham |
| Nombre del de productor, editor, distribuidor, fabricante |
Springer |
| Fecha de producción, publicación, distribución, fabricación o copyright |
2017. |
| 300 ## - DESCRIPCIÓN FÍSICA |
|---|
| Extensión |
1 recurso en línea |
| 336 ## - TIPO DE CONTENIDO |
|---|
| Término de tipo de contenido |
Texto |
| Código de tipo de contenido |
txt |
| Fuente |
rdacontent |
| 337 ## - TIPO DE MEDIO |
|---|
| Nombre/término del tipo de medio |
electrónico |
| Código del tipo de medio |
c |
| Fuente |
rdamedia |
| 338 ## - TIPO DE SOPORTE |
|---|
| Nombre/término del tipo de soporte |
recurso electrónico |
| Código del tipo de soporte |
cr |
| Fuente |
rdacarrier |
| 347 ## - CARACTERÍSTICAS DEL ARCHIVO DIGITAL |
|---|
| Tipo de archivo |
text file |
| Formato de codificación |
PDF |
| 500 ## - NOTA GENERAL |
|---|
| Nota general |
SpringerLink |
| 505 0# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
Endocannabinoids and Lipid Mediators in Brain Functions; Contents; List of Committed Contributors; The Endocannabinoid System in Leptin-Driven Changes of Orexinergic Signaling Under Physiological and Pathological Conditions; 1 Endocannabinoids and Cannabinoid Receptor Type 1: An Overview; 2 Orexin/Hypocretin: Discovery and Characterization; 3 Orexin Receptors: Common Signaling with CB1; 4 Anatomical Overlap Between Cannabinoid and Orexin Receptor Distribution in the Brain; 5 Molecular Interactions Between Cannabinoid and Orexin Receptors |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
3.4 Hippocampus3.5 Amygdala; 3.6 Periaqueductal Gray; 3.7 Nucleus Accumbens; 3.8 Ventral Tegmental Area; 3.9 Cerebellum; 3.10 Basal Ganglia; 4 Hormonal Influence on CB1Rs; 5 Conclusions; References; Endocannabinoids, Stress, and Negative Affect; 1 Neuroendocrine Response to Stress; 2 Introduction to the Endocannabinoid System; 3 Role of the Endocannabinoid System in the Acute Effects of Stress; 4 Role of the ECB System in the Effects of Chronic Stress; 5 Stress-Related Negative Affect and Drug Withdrawal; 5.1 Stress-Related Negative Affective Behavior; 5.2 Drug Withdrawal |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
5 Subcellular Distribution of Neuronal CB1 Receptors6 Polarized CB1 Targeting in Neurons; 7 Polarized CB1R Signaling in Neurons; 8 A Special Case: CB1 at the Presynaptic Terminal; 9 Conclusion; References; Endocannabinoid-Dependent Synaptic Plasticity in the Striatum; 1 Introduction; 1.1 The Endocannabinoid System in the Striatum; 1.1.1 Striatal Neurons; 1.2 Endocannabinoid System Expression in the Striatum; 2 Cannabinoid Receptor-Mediated Regulation of Synaptic Transmission; 2.1 Effects of Cannabinoids on GABAergic and Glutamatergic Synaptic Transmission |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
5.3 Sex Differences in Negative Affect and Drug Withdrawal6 Implications for the Development of ECB-Based Therapeutics; 7 Summary; References; Cell-Autonomous Endocannabinoid Production Shapes Polarized and Dynamic Distribution and Signaling Patterns of Cannabinoid CB1...; 1 Polarized Distribution of Neuronal Plasma Membrane Components; 2 GPCR Activation State Depends on the Plasma Membrane Environment; 3 The CB1 Cannabinoid Receptor: A Structurally Instable GPCR; 4 Ubiquitous Neuronal Membrane Component Endocannabinoids Produce Tonic CB1 Activation |
| 505 8# - NOTA DE CONTENIDO CON FORMATO |
|---|
| Nota de contenido con formato |
6 Functional Interaction Between Cannabinoid and Orexin Receptors Under Leptin Signal Deficiency: Emerging Studies6.1 Appetite and Energy Homeostasis; 6.2 Reward, Arousal, and Seeking Behavior; 6.3 Sleep/Wakefulness; 6.4 Nociception; References; How CB1 Receptor Activity and Distribution Contribute to Make the Male and Female Brain Different Toward Cannabinoid-Induced E...; 1 Brain Sexual Dimorphisms and the Endocannabinoid System; 2 Sex-Dependent Effects of Cannabinoids; 3 CB1R Density and Function in the Male and Female Brain; 3.1 Prefrontal Cortex; 3.2 Thalamus; 3.3 Hypothalamus |
| 520 3# - SUMARIO, ETC. |
|---|
| Sumario, etc. |
The science of cannabinoids is 50 years old. These past years provided a remarkable and constant number of breakthroughs, showing that the signaling mediated by endocannabinoids and lipid mediators impacts almost every function of the body. Indeed, this represents a special field of research, which allows tackling the complexity of biological functions, and provides potential therapeutic frameworks for a plethora of diseases. The number of exciting discoveries brought up to the scientific community almost on a daily basis highlights the importance of an updated volume on this topic. Particularly, given that potential therapeutic benefits of cannabis and cannabinoids are currently under heavy analysis in many Countries worldwide. Hence, the main objective of this book is to explore not only some of the many functions of endocannabinoids (and lipid mediators) in physiological control of networks at a cellular and molecular level, but also to extend this knowledge for potential use of cannabinoids and/or drugs regulating endocannabinoid levels in vivo as therapeutic target(s) in neurological and neuropsychiatric disorders. In this book new findings and ideas about the endocannabinoid system and its roles as neuronal circuit modulator related to human brain pathologies characterized by alterations in neuroplasticity will be highlighted. Endocannabinoid roles in key systems controlling appetite, pain, learning and memory, as well as sleep and stress responses will be presented. In addition, pathological processes associated with changes in endocannabinoid signaling will be discussed in the context of anxiety, autism, depression and addiction. This book will provide an excellent background to researchers looking for extending their areas of interest, and to newcomers in the field. |
| 988 ## - NOTA LOCAL 598 |
|---|
| Nota local 598 (boletines) |
EBOOK, EBSPRINGER_2017D |
| 650 #4 - PUNTO DE ACCESO ADICIONAL DE MATERIA--TÉRMINO DE MATERIA |
|---|
| 9 (RLIN) |
330208 |
| Término de materia o nombre geográfico como elemento de entrada |
Cannabis |
| Subdivisión general |
Efectos fisiológicos |
| 650 #7 - PUNTO DE ACCESO ADICIONAL DE MATERIA--TÉRMINO DE MATERIA |
|---|
| Fuente del encabezamiento o término |
embne |
| 9 (RLIN) |
147710 |
| Término de materia o nombre geográfico como elemento de entrada |
Cannabis |
| 700 1# - PUNTO DE ACCESO ADICIONAL--NOMBRE DE PERSONA |
|---|
| Nombre de persona |
Melis, Miriam. |
| 856 40 - LOCALIZACIÓN Y ACCESO ELECTRÓNICOS |
|---|
| Identificador Uniforme del Recurso |
https://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-57371-7 |
| Nota pública |
Acceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 ## - ELEMENTOS DE PUNTO DE ACCESO ADICIONAL (KOHA) |
|---|
| Fuente del sistema de clasificación o colocación |
Library of Congress Classification |
| Tipo de ítem Koha |
LIBRO-E NO PRÉSTAMO |
| 998 ## - DATOS ESTADÍSTICOS |
|---|
| Fecha de catalogación |
02/2018 |
| Tipo de materia |
E-book |
| Catalogador |
|
| Catalogado |
Sí |